First-in-Class Drug Approved for Insomnia E2006, a novel dual orexin receptor antagonist (DORA), has shown efficacy for both subject-reported sleep onset and maintenance on sleep diary measures, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback